- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05901064
Evaluation of Ultrasonic Scissors and Diathermy for Axillary Clearance in Breast Cancer Patients (SEROM)
Economic Comparison Between the Use of Ultrasonic Scissors and Diathermy for Axillary Clearance in Breast Cancer Patients
Study Overview
Detailed Description
Breast surgery plays an important role in the treatment of breast cancer. Sometimes cancer cells can spread to lymph nodes in the axill. The first lymph node affected in the armpit is called the sentinel node. Surgery to remove this node can answer the question of whether the cancer has spread to the axill. If the node is affected, further surgery is performed to remove most of the lymph nodes in the armpit, a so-called axillary clereance.
The breast unit at Linköping University Hospital performs about 60 axillary clereance per year. Axillary clereance is associated with a number of complications, such as infections, bleeding, pain, loss of sensation and limited mobility in the arm.
Accumulation of wound fluid in the surgical area is common, affecting about a quarter of patients undergoing surgery. Small amounts of wound fluid usually do not require treatment, but larger accumulations usually require drainage. Patients who have symptoms from armpit wound fluid have to make repeated return visits so that a nurse drains the fluid using a needle. This poses several risks to the patient such as infection and/or bleeding. This, in turn, can delay the start of additional treatment and can put a financial burden on both the patient and the healthcare system.
Today, the investigators use a device with a weak electric current (diathermy) to remove lymph nodes from the armpit. Harmonic Focus ® is a pair of scissors that instead uses ultrasound waves to divide the tissue. There are scientific studies showing that the use of ultrasonic scissors reduces the risk of fluid accumulation and thus the risk of complications after surgery[1, 2]. The investigators want to conduct a prospective study, an economic analysis comparing the costs of using diathermy versus Harmonic Focus®.
In addition, patients will complete a quality of life questionnaire before surgery, approximately 4-6 weeks after and one year after surgery. The results of the questionnaires will be compared between the Harmonic Focus® and the diathermy group.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Östergötland
-
Linköping, Östergötland, Sweden, 58185
- Recruiting
- University Hospital of Linkoping
-
Contact:
- Carlos Dussan, MD, PhD
- Phone Number: +46706390116
- Email: carlos.dussan.luberth@regionostergotland.se
-
Contact:
- Ervin Beka, MD, PhD-student
- Phone Number: +46738430968
- Email: ervin.beka@regionostergotland.se
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 18 years or older
- All patients who will undergo axillary evacuation
- Informed consent
Exclusion Criteria:
- Patients who have previously undergone axillary evacuation.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Harmonic Focus
Patients that are operated with Harmonic Focus
|
Evaluating the use of Harmonic Focus in axillary clearance due to metastasis of breast cancer in axilla
Other Names:
|
|
Active Comparator: Diathermy
Patients that are operated with conventional diathermy
|
Evaluating the use of Harmonic Focus in axillary clearance due to metastasis of breast cancer in axilla
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Economic comparison between the use of ultrasonic scissors and diathermy for axillary dissection in breast cancer patients.
Time Frame: 12 months
|
Unit of measures: Costs of extra visits with nurse, physiotherapist or surgeon, antibiotics, PICO, re-interventions due to complications, microbiological cultures, incapacity to work, hospitalizations
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Function before and after breast cancer treatment. Lymph-ICF Survey
Time Frame: 12 months
|
Questionnaire
|
12 months
|
|
Complication frequency between the use of ultrasonic scissors and diathermy for axillary
Time Frame: 12 months
|
Comlplication frequency comparison
|
12 months
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, McCall LM, Morrow M. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011 Feb 9;305(6):569-75. doi: 10.1001/jama.2011.90.
- Bohm D, Kubitza A, Lebrecht A, Schmidt M, Gerhold-Ay A, Battista M, Stewen K, Solbach C, Kolbl H. Prospective randomized comparison of conventional instruments and the Harmonic Focus((R)) device in breast-conserving therapy for primary breast cancer. Eur J Surg Oncol. 2012 Feb;38(2):118-24. doi: 10.1016/j.ejso.2011.11.003. Epub 2011 Dec 5.
- Faisal M, Fathy H, Shaban H, Abuelela ST, Marie A, Khaled I. A novel technique of harmonic tissue dissection reduces seroma formation after modified radical mastectomy compared to conventional electrocautery: a single-blind randomized controlled trial. Patient Saf Surg. 2018 May 17;12:8. doi: 10.1186/s13037-018-0155-3. eCollection 2018.
- Galimberti V, Cole BF, Zurrida S, Viale G, Luini A, Veronesi P, Baratella P, Chifu C, Sargenti M, Intra M, Gentilini O, Mastropasqua MG, Mazzarol G, Massarut S, Garbay JR, Zgajnar J, Galatius H, Recalcati A, Littlejohn D, Bamert M, Colleoni M, Price KN, Regan MM, Goldhirsch A, Coates AS, Gelber RD, Veronesi U; International Breast Cancer Study Group Trial 23-01 investigators. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. Lancet Oncol. 2013 Apr;14(4):297-305. doi: 10.1016/S1470-2045(13)70035-4. Epub 2013 Mar 11. Erratum In: Lancet Oncol. 2013 Jun;14(7):e254.
- de Boniface J, Frisell J, Andersson Y, Bergkvist L, Ahlgren J, Ryden L, Olofsson Bagge R, Sund M, Johansson H, Lundstedt D; SENOMAC Trialists' Group. Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial. BMC Cancer. 2017 May 26;17(1):379. doi: 10.1186/s12885-017-3361-y.
- Sowa Y, Numajiri T, Kawarazaki A, Sakaguchi K, Taguchi T, Nishino K. Preventive effects on seroma formation with use of the harmonic focus shears after breast reconstruction with the latissimus dorsi flap. J Plast Surg Hand Surg. 2016 Dec;50(6):349-353. doi: 10.1080/2000656X.2016.1178129. Epub 2016 May 5.
- Selvendran S, Cheluvappa R, Tr Ng VK, Yarrow S, Pang TC, Segara D, Soon P. Efficacy of harmonic focus scalpel in seroma prevention after axillary clearance. Int J Surg. 2016 Jun;30:116-20. doi: 10.1016/j.ijsu.2016.04.041. Epub 2016 Apr 29.
- Hung SH, Chu D, Chen FM, Chen T, Chen RC. Evaluation of the harmonic scalpel in breast conserving and axillary staging surgery. J Chin Med Assoc. 2012 Oct;75(10):519-23. doi: 10.1016/j.jcma.2012.07.006. Epub 2012 Sep 15.
- He Q, Zhuang D, Zheng L, Fan Z, Zhou P, Zhu J, Lv Z, Chai J, Cao L. Harmonic focus versus electrocautery in axillary lymph node dissection for breast cancer: a randomized clinical study. Clin Breast Cancer. 2012 Dec;12(6):454-8. doi: 10.1016/j.clbc.2012.07.014. Epub 2012 Oct 3.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- LinkoepingU
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Seroma
-
Omphis FoundationConsorci Sanitari del MaresmeRecruitingSeroma Following ProcedureSpain
-
Zagazig UniversityCompletedPost-mastectomty SeromaEgypt
-
Jianyi LiEnrolling by invitationSeroma Following Procedure | Postoperative Seroma Rate, Drainage Tube Removal Time, and Capsular Contracture RateChina
-
Anselm TamminenNot yet recruitingSeroma Complicating A Procedure
-
SOMAVAC Medical SolutionsUniversity of TennesseeUnknownHematoma Postoperative | Seroma as Procedural ComplicationUnited States
-
Michigan State UniversityCompletedInfected Seroma After Surgical ProcedureUnited States
-
Severance HospitalCompletedSeroma as Procedural ComplicationKorea, Republic of
-
Ikechukwu Bartholomew UlasiCompleted
-
Ittefaq Hospital trustCompletedBreast Cancer Surgery | Post-operative Seroma FormationPakistan
-
Sindh Institute of Urology and TransplantationRecruitingInfections | Pain, Postoperative | Seroma Following ProcedurePakistan
Clinical Trials on Axillary clearance
-
Karolinska InstitutetUppsala University; Centrallasarettet VästeråsCompleted
-
Karolinska InstitutetThe Swedish Research Council; Swedish Cancer Foundation; Nordic Cancer UnionActive, not recruitingBreast CancerSweden, Denmark, Greece
-
Parc de Salut MarGEICAMRecruiting
-
Azienda Socio Sanitaria Territoriale della Valle...RecruitingCopd | Bronchiectasis AdultItaly
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedStage II Breast Cancer AJCC v6 and v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Breast Carcinoma Metastatic in Lymph Node | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7United States
-
Seoul National University HospitalAsan Medical CenterRecruitingBreast Cancer | Neoadjuvant Therapy | Sentinel Lymph Node BiopsySouth Korea
-
The Second Hospital of Hebei Medical UniversityUnknown
-
Medipol UniversityRecruitingBreast Cancer | Breast Neoplasms | Breast Cancer FemaleTurkey
-
MetroHealth Medical CenterCompletedWounds and Injuries | ComaUnited States
-
Hill-RomCompleted